American Portfolios Advisors Nevro Corp Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Mar 21, 2023
BUY
$59.95 - $92.06 $899 - $1,380
15 New
15 $1.09 Million
Q4 2021

Mar 21, 2023
BUY
$81.07 - $121.29 $1,216 - $1,819
15 New
15 $1.22 Million
Q3 2021

Mar 22, 2023
BUY
$101.99 - $166.36 $1,529 - $2,495
15 New
15 $1.75 Million
Q2 2021

Mar 22, 2023
BUY
$141.6 - $179.06 $2,124 - $2,685
15 New
15 $2.49 Million
Q1 2021

Mar 22, 2023
BUY
$132.81 - $182.18 $1,992 - $2,732
15 New
15 $2.09 Million
Q4 2020

Mar 22, 2023
BUY
$138.17 - $184.34 $2,072 - $2,765
15 New
15 $2.6 Million
Q3 2020

Mar 22, 2023
BUY
$114.09 - $145.51 $1,711 - $2,182
15 New
15 $2.09 Million

Others Institutions Holding NVRO

# of Institutions
152
Shares Held
39.1M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $183M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email